Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis

Cell(2021)10.1016/j.cell.2021.02.048Source: DataRank Database

Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis is a research paper published in Cell (2021). On theSindex it has a DataRank of 0. It has been cited 203 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access203 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: bronzeTopics (49)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (19)

Daniel W. Beury,Vishaka Gopalan,Arielle K. Tycko,Haiying Qin ORCID,Miranda E. Clements

Live enrichment

PubMed:33765443

NCI NIH HHS

Grant: U01 CA224766

Intramural NIH HHS

Grant: Z99 CA999999

Intramural NIH HHS

Grant: ZIA BC011332

Intramural NIH HHS

Grant: ZIA BC011334

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

publisherhttp://www.cell.com/article/S0092867421002373/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0092867421002373?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0092867421002373?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8344805

Fields of Study

Adaptive ImmunityAnimalsCell Line, TumorGenetic EngineeringHumansImmunosuppression TherapyInterleukin-12LungLung NeoplasmsLymphocyte ActivationMaleMiceMice, Inbred C57BLMice, TransgenicMyeloid CellsNeoplasm MetastasisRhabdomyosarcomaSurvival RateT-LymphocytesTumor Microenvironment

MeSH Terms

Keywords

T cellscancer immunologygenetically engineered myeloid cellsimmune suppressionimmunotherapyinterleukin 12metastasis tumor microenvironmentpre-metastatic nichestem cell niche